| Literature DB >> 29467329 |
Kristin M Scheible1, Jason Emo1, Nathan Laniewski2, Andrea M Baran3, Derick R Peterson3, Jeanne Holden-Wiltse3, Sanjukta Bandyopadhyay3, Andrew G Straw3, Heidie Huyck1, John M Ashton2, Kelly Schooping Tripi2, Karan Arul4, Elizabeth Werner1, Tanya Scalise1, Deanna Maffett1, Mary Caserta1, Rita M Ryan5, Anne Marie Reynolds6, Clement L Ren7, David J Topham2, Thomas J Mariani1, Gloria S Pryhuber1.
Abstract
The inverse relationship between gestational age at birth and postviral respiratory morbidity suggests that infants born preterm (PT) may miss a critical developmental window of T cell maturation. Despite a continued increase in younger PT survivors with respiratory complications, we have limited understanding of normal human fetal T cell maturation, how ex utero development in premature infants may interrupt normal T cell development, and whether T cell development has an effect on infant outcomes. In our longitudinal cohort of 157 infants born between 23 and 42 weeks of gestation, we identified differences in T cells present at birth that were dependent on gestational age and differences in postnatal T cell development that predicted respiratory outcome at 1 year of age. We show that naive CD4+ T cells shift from a CD31-TNF-α+ bias in mid gestation to a CD31+IL-8+ predominance by term gestation. Former PT infants discharged with CD31+IL8+CD4+ T cells below a range similar to that of full-term born infants were at an over 3.5-fold higher risk for respiratory complications after NICU discharge. This study is the first to our knowledge to identify a pattern of normal functional T cell development in later gestation and to associate abnormal T cell development with health outcomes in infants.Entities:
Keywords: Adaptive immunity; Development; Immunology
Mesh:
Substances:
Year: 2018 PMID: 29467329 PMCID: PMC5916253 DOI: 10.1172/jci.insight.96724
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708